Palivizumab

Definition: Palivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology used to prevent severe disease caused by respiratory syncytial virus (RSV) infections. It is recommended for infants at high-risk for RSV due to conditions such as prematurity or other medical problems including heart or lung diseases. The most common side effects include fever and rash. source: Wikipedia

ID

386900007

ID date

20 Jul 2007

Previous ID

4843211000001103

Name

Palivizumab